Tirzepatide — Dosage Calculator & Complete GuideCategory: GLP-1 Agonist | Half-Life: ~5 days | Route: SubQDual GIP/GLP-1 receptor agonist. More effective for weight loss than semaglutide in head-to-head trials. FDA approved as Mounjaro and Zepbound.Dosing Information

Starting Dose: 2.5mg weekly

Target Dose: 5-15mg weekly

Research Status: FDA approved (Mounjaro / Zepbound)

Primary Uses

Chronic weight management

Type 2 diabetes

Obesity

Metabolic syndrome

Benefits

Superior weight loss (20-25% in trials)

Better glycemic control than semaglutide

Improved insulin sensitivity

May preserve lean muscle mass

Cardiovascular benefits

Calculate Tirzepatide DoseUse VialDex to calculate the exact reconstitution volume and syringe dose for Tirzepatide. Enter your vial size and BAC water volume for instant results.Open VialDex Calculator | Browse All Peptides | Check Compatibility

VIALDEX